|
RNF217 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.39042119432042E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.13779999866281E-08 |
| Normal-vs-Stage2 |
1.00409999981288E-07 |
| Normal-vs-Stage3 |
4.40559810854779E-11 |
| Normal-vs-Stage4 |
2.16829998400669E-09 |
| Stage1-vs-Stage2 |
2.128200E-01 |
| Stage1-vs-Stage3 |
1.875670E-03 |
| Stage1-vs-Stage4 |
3.423700E-02 |
| Stage2-vs-Stage3 |
4.072400E-01 |
| Stage2-vs-Stage4 |
6.680800E-01 |
| Stage3-vs-Stage4 |
7.205400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.1633030356536E-11 |
| Normal-vs-AfricanAmerican |
1.461420E-03 |
| Normal-vs-Asian |
6.93860000011703E-07 |
| Caucasian-vs-AfricanAmerican |
4.544800E-01 |
| Caucasian-vs-Asian |
7.147200E-01 |
| AfricanAmerican-vs-Asian |
6.176000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.48139953029636E-10 |
| Normal-vs-Female |
1.59909974151162E-10 |
| Male-vs-Female |
5.962100E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.04530000397818E-08 |
| Normal-vs-Age(41-60Yrs) |
3.11070058600649E-11 |
| Normal-vs-Age(61-80Yrs) |
9.05390207250889E-11 |
| Normal-vs-Age(81-100Yrs) |
2.212400E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.236400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.222300E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.518100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.214800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.765000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.495800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.59539999999847E-06 |
| Classical-VS-Follicular |
6.115000E-03 |
| Classical-VS-Other |
4.409400E-01 |
| Classical-VS-Normal |
4.43220005141853E-09 |
| Tall-VS-Follicular |
1.030200E-01 |
| Tall-VS-Other |
2.214600E-01 |
| Tall-VS-Normal |
3.98592270300924E-12 |
| Follicular-VS-Other |
8.855000E-01 |
| Follicular-VS-Normal |
5.20820053750981E-11 |
| Other-VS-Normal |
5.741900E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.31570335024389E-11 |
| Normal-vs-N1 |
4.88850000479601E-08 |
| N0-vs-N1 |
9.384800E-01 |
|
|
